Evolving Concepts in Phases I and II Drug Development for Crohn's Disease

Journal of Crohn's & colitis

Volumn 11, Issue 2, 2017, Pages 246-255

  Jairath, Vipul ^a,b   Levesque, Barrett G ^a,b   Vande Casteele, Niels ^a,b   Khanna, Reena ^a   Mosli, Mahmoud ^b   Hindryckx, Pieter ^a,b   Travis, Simon ^b   Duijvenstein, Marjolejn ^b   Rimola, Jordi ^a   Panes, Julian ^a   D'Haens, Geert ^a,b   Sandborn, William J ^a,b   Feagan, Brian G ^a,b  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

clinical trials; Crohn s disease

Indexed keywords

GASTROINTESTINAL AGENT;

CLASSIFICATION; CROHN DISEASE; DRUG APPROVAL; DRUG DEVELOPMENT; HUMAN; ORGANIZATION AND MANAGEMENT; PROCEDURES; TREATMENT OUTCOME;

CROHN DISEASE; DRUG APPROVAL; DRUG DISCOVERY; GASTROINTESTINAL AGENTS; HUMANS; TREATMENT OUTCOME;

EID: 85020685495     PISSN: None     EISSN: 18764479     Source Type: Journal    
DOI: 10.1093/ecco-jcc/jjw137     Document Type: Review

References (0)